Ignite Creation Date:
2025-12-24 @ 4:11 PM
Ignite Modification Date:
2025-12-24 @ 4:11 PM
Study NCT ID:
NCT04539366
Status:
SUSPENDED
Last Update Posted:
2025-11-03
First Post:
2020-09-04
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, The GD2-CAR PERSIST Trial
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-25
Start Date Type:
ACTUAL
Primary Completion Date:
2040-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2040-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-04
First Submit QC Date:
None
Study First Post Date:
2020-09-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-31
Last Update Post Date:
2025-11-03
Last Update Post Date Type:
ESTIMATED